Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 424B3 Offering Prospectus
  8. 10QSB Other 10QSB
  9. REGDEX Other REGDEX
  10. DEF 14A Proxy Proxy Statement
  11. PRER14A Other PRER14A
  12. 8-K Event Item 5
  13. PRE 14A Proxy Proxy Statement (Preliminary)
  14. 424B3 Offering Prospectus
  15. S-3/A Offering Registration Statement
  16. 10-Q Report Quarterly Report
  17. S-3/A Offering Registration Statement
  18. 10KSB Other 10KSB
  19. SC 13G Stake Amended Statement of Ownership
  20. S-3 Offering Registration Statement

Page 65 of 72 · 1,429 filings